Literature DB >> 24743456

Impact of habitual exercise on the strength of individuals with myotonic dystrophy type 1.

Lauren I Brady1, Lauren G MacNeil, Mark A Tarnopolsky.   

Abstract

OBJECTIVE: It remains unclear whether habitual physical activity can attenuate the rate of progressive muscle strength loss in individuals with myotonic dystrophy type 1 (DM1). The aim of this study was to identify whether there were any strength differences between DM1 patients who were habitually active or sedentary.
DESIGN: Knee extension, handgrip, and elbow flexion quantitative strength measurements were investigated in the DM1 patients using isokinetic dynamometry. Strength was compared between the patients who followed self-selected formal exercise plans for at least 1 yr, those who were sedentary (controls), and those who initiated or terminated a formal exercise routine.
RESULTS: Physically active DM1 patients with midrange CTG repeat size (100-500 CTG repeat sizes) had significantly stronger handgrip and knee extension and elbow flexion torques as compared with their sedentary counterparts with the same CTG repeat range. The DM1 patients who began a formal exercise routine experienced a significant improvement in knee extension torque measurements (+24.3%) in comparison with those who were habitually active or sedentary.
CONCLUSIONS: These data suggest that there is an association between physical activity and strength. This may be shown to be a useful tool for the management of this condition. Further investigations into the relationships between physical exercise, muscle weakness, and genetic factors are needed before evidence-based recommendations can be made.

Entities:  

Mesh:

Year:  2014        PMID: 24743456     DOI: 10.1097/PHM.0000000000000088

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  6 in total

1.  Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.

Authors:  Alexander Manta; Derek W Stouth; Donald Xhuti; Leon Chi; Irena A Rebalka; Jayne M Kalmar; Thomas J Hawke; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

2.  Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.

Authors:  Marie-Pier Roussel; Marie-Michèle Fiset; Laurie Gauthier; Claudia Lavoie; Émilie McNicoll; Laurie Pouliot; Cynthia Gagnon; Elise Duchesne
Journal:  J Neurol       Date:  2021-04-27       Impact factor: 4.849

Review 3.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.

Authors:  Lydia Sharp; Diana C Cox; Thomas A Cooper
Journal:  Muscle Nerve       Date:  2019-10-23       Impact factor: 3.217

5.  Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes.

Authors:  Andrew I Mikhail; Peter L Nagy; Katherine Manta; Nicholas Rouse; Alexander Manta; Sean Y Ng; Michael F Nagy; Paul Smith; Jian-Qiang Lu; Joshua P Nederveen; Vladimir Ljubicic; Mark A Tarnopolsky
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

Review 6.  Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.

Authors:  Elizabeth M McNally; Douglas L Mann; Yigal Pinto; Deepak Bhakta; Gordon Tomaselli; Saman Nazarian; William J Groh; Takuhisa Tamura; Denis Duboc; Hideki Itoh; Leah Hellerstein; Pradeep P A Mammen
Journal:  J Am Heart Assoc       Date:  2020-02-06       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.